FDA approves Empliciti, a new immune-stimulating therapy to treat multiple myeloma News FDA approves Empliciti, a new immune-stimulating therapy to treat multiple myeloma
FDA approves Portrazza to treat advanced squamous non-small cell lung cancer News FDA approves Portrazza to treat advanced squamous non-small cell lung cancer
FDA approves Darzalex for patients with previously treated multiple myeloma News FDA approves Darzalex for patients with previously treated multiple myeloma
